» Articles » PMID: 20564225

Novel Regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) Transcription by Glucocorticoids: Cooperative Effects of the Glucocorticoid Receptor, C/EBP Beta, and the Vitamin D Receptor in 24(OH)ase Transcription

Overview
Journal J Cell Biochem
Date 2010 Jun 22
PMID 20564225
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Glucocorticoid-induced bone loss has been proposed to involve direct effects on bone cells as well as alterations in calcium absorption and excretion. Since vitamin D is important for the maintenance of calcium homeostasis, in the present study the effects of glucocorticoids on vitamin D metabolism through the expression of 24(OH)ase, an enzyme involved in the catabolism of 1,25(OH)(2)D(3), were examined. Injection of vitamin D replete mice with dexamethasone (dex) resulted in a significant induction in 24(OH)ase mRNA in kidney, indicating a regulatory effect of glucocorticoids on vitamin D metabolism. Whether glucocorticoids can affect 24(OH)ase transcription is not known. Here we demonstrate for the first time a glucocorticoid receptor (GR) dependent enhancement of 1,25(OH)(2)D(3)-induced 24(OH)ase transcription. Dex treatment of GR and vitamin D receptor (VDR) transfected COS-7 cells and dex treatment of osteoblastic cells (in which VDR and GR are present endogenously) potentiated 1,25(OH)(2)D(3)-induced 24(OH)ase transcription. In addition, GR was found to cooperate with C/EBP beta to enhance VDR-mediated 24(OH)ase transcription. Using the rat 24(OH)ase promoter with the C/EBP site mutated, GR-mediated potentiation of 1,25(OH)(2)D(3)-induced 24(OH)ase transcription was inhibited. Immunoprecipitation indicated that that GR can interact with C/EBP beta and ChIP/re-ChIP analysis showed that C/EBP beta and GR bind simultaneously to the 24(OH)ase promoter. These findings indicate a novel mechanism whereby glucocorticoids can alter VDR-mediated 24(OH)ase transcription through functional cooperation between C/EBP beta and GR that results in an enhanced ability of C/EBP beta to cooperate with VDR in the regulation of 24(OH)ase.

Citing Articles

Poor bone health in Duchenne muscular dystrophy: a multifactorial problem beyond corticosteroids and loss of ambulation.

Hurley-Novatny A, Chang D, Murakami K, Wang L, Li H Front Endocrinol (Lausanne). 2024; 15():1398050.

PMID: 39669499 PMC: 11634624. DOI: 10.3389/fendo.2024.1398050.


Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity-A Comprehensive Review and Clinical Insight.

Aberger S, Schreiber N, Pilz S, Eller K, Rosenkranz A, Kirsch A Int J Mol Sci. 2024; 25(18).

PMID: 39337491 PMC: 11431961. DOI: 10.3390/ijms251810003.


Vitamin D in pituitary driven osteopathies.

Chiloiro S, Costanza F, Riccardi E, Giampietro A, De Marinis L, Bianchi A Pituitary. 2024; 27(6):847-859.

PMID: 39180644 PMC: 11632065. DOI: 10.1007/s11102-024-01439-3.


Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol Supplementation.

Karonova T, Mikhaylova A, Golovatyuk K, Chernikova A, Korobova Z, Liubimova N Diagnostics (Basel). 2024; 14(13).

PMID: 39001298 PMC: 11240998. DOI: 10.3390/diagnostics14131408.


The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.

Dhayat N, Mattmann C, Seeger H, Ritter A, Ernandez T, Stoermann-Chopard C Kidney Int Rep. 2024; 9(4):1072-1082.

PMID: 38765596 PMC: 11101794. DOI: 10.1016/j.ekir.2024.01.004.